Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase de ciency is a possible cause of hyponatraemia in the neonate. Elevated 17-hydroxyprogesterone (17-OHP) is considered diagnostic of the condition, although there have been reports of anomalous high concentrations, up to 110 nmol/L, in premature, sick infants subsequently shown to have normal adrenocortical function.
Introduction
The mechanisms that regulate water and sodium metabolism during the neonatal period are precarious. For example, the ability to concentrate urine is poorly developed in infants less than 2 months of age, 1,2 and the stress of illness and/or renal tubular immaturity in pre-term babies can further compound the problem. 3 Hyponatraemia in neonates may be caused by relative water excess in relation to sodium, intrinsic impairment in renal ability to conserve sodium, or inadequate secretion of mineralocorticoids, as in babies with congenital adrenal hyperplasia (CAH) due to 21hydroxylase de¢ciency. Plasma 17-hydroxyprogesterone (17-OHP) concentration may be requested for di¡erential diagnosis. We describe a case which highlights the clinical limitations of such a request in a sick baby with hyponatraemia.
Case report
Our patient was a 6-week-old girl admitted for breathing di¤culties and poor feeding of 1 day's dura-tion. The parents were of Asian origin (¢rst cousins) and the baby was born by Caesarean section for breech presentation at 37 weeks. She was healthy and had developed well since birth. Clinical examination on admission revealed a drowsy and ill-looking baby with a temperature of 35.58C, respiratory rate of 50/min, nasal £are, tracheal tugging, subcostal and intercostal recession and crackles in the right lung ¢eld. Chest Xray showed right upper lobe collapse and consolidation. A provisional diagnosis of bronchiolitis was made and treatment with intravenous (iv) ampicillin /cefotaxime was initiated and continued for 1 week. Routine urea and electrolyte measurements showed signi¢cant hyponatraemia, with a plasma sodium of 122 mmol/ L, declining further to 120 mmol/ L a few hours after admission (reference range 1281 46 mmol/ L). In view of this, an iv infusion of 5% dextrose in 0.45% saline was initiated; however, the hyponatraemia persisted for a further three days (range 117^124 mmol/ L). Plasma concentrations of potassium varied from 3.1 to 5.4 mmol/ L (reference range 3.4^6.1mmol/ L) during this period, and sodium loss in the urine was considerable, ranging from 43^123 mmol/ L. Throughout the entire episode, the baby's plasma creatinine concentration ranged between 17^27 mmol/ L (reference range 535 mmol/ L). Other biochemical parameters were either normal or unremarkable.
By day 4, the baby's plasma sodium concentration had risen to 131mmol/ L and the iv sodium infusion was stopped. Plasma sodium concentration continued to increase during the next 6 days, reaching a peak of 141 mmol/ L. Plasma 17-OHP was requested on day 2 and the result was elevated, at 300 nmol/ L, as measured by an in-house radioimmunoassay (RIA) method utiliz ing a solvent extraction step in order to reduce interference prior to immunoassay (reference value 513 nmol/ L in full term, healthy babies; 540 nmol/ L if stressed). Plasma cortisol concentration (Abbott AxSym; Abbott Laboratories Ltd, Maidenhead, Berkshire, UK) was extremely high, at 41600 nmol/ L (reference range 50^600 nmol/ L). Repeat analysis using another cortisol platform (Bayer ACS180; Bayer plc, Newbury, Berkshire, UK) also revealed a very high plasma concentration of 2746 nmol/ L.
Despite the signi¢cantly increased 17-OHP concentration, the diagnosis of CAH was considered unlikely in view of the lack of virilization of the baby's genitalia and the concomitant grossly raised cortisol concentration; accordingly, the baby was not treated with steroids. Such doubt was further substantiated when, by day 6, the baby's condition had improved and plasma and urine electrolyte concentrations became normal. Plasma 17-OHP and cortisol concentrations declined to 18 nmol/ L and 329 nmol/ L, respectively, and the baby was discharged 4 days later.
Other steroids such as androstenedione, DHAS and aldosterone were also measured on day 2, by in-house assays. Both androstenedione and aldosterone assays used an extraction step prior to immunoassay. The DHAS assay was a direct method performed without extraction. The concentrations of androstenedione and DHAS were 116 nmol/ L and 15.6 mmol/L, respectively, and fell within the range noted in patients with CAH. Aldosterone concentration, at1455 pmol/ L, was di¤cult to interpret and unhelpful in view of the baby's precarious state of natraemia, hydration and treatment with saline infusion. Plasma renin activity was not measured because of insu¤cient sample, nor were repeat measurements by techniques such as GCMS performed for any of the steroids measured. By day 6 androstenedione, DHAS and aldosterone had decreased to within reference limits.
Two weeks after discharge, the baby was reviewed in the outpatient clinic and plasma and urine electrolytes, 17-OHP and cortisol concentrations were all within reference limits. To further exclude the possi-bility of partial 21-hydroxylase de¢ciency, a short Synacthen test was carried out 8 weeks later (at a chronological age of 17 weeks). After Synacthen (3.5 mg/kg body weight given iv as a bolus), the17-OHP concentration increased from 10 to 23 nmol/ L at 30 min, with cortisol increasing from 391 to 861 nmol/ L, values highly consistent with normal adrenocortical function.
Discussion
Sodium handling by the kidney is poor during early neonatal life. Children over 1 year of age are capable of handling enormous variations in sodium intake, ranging from 2 to 1000 mmol, but neonates are less capable of excreting and/or retaining sodium 3 and this problem is further compounded by prematurity. The infant glomerulus is about one-third the size of the adult glomerulus, the proximal convoluted tubules are about one-tenth the length and the loops of Henle are also short. These, together with other factors such as low blood pressure and a high haematocrit, reduce the glomerular ¢ltration rate in neonates even when it is expressed as a factor of adult weight or surface area. The ability to concentrate urine is also poor in infants, in the main, due to the low urea concentration in the renal medullary interstitium, making the counter current system less e¡ective. 3 Although acute imbalance in plasma sodium occurs relatively easily in the ¢rst few weeks of infant life because of limited renal capacity, measurement of plasma 17-OHP concentration remains a justi¢able request in order to exclude 21-hydroxylase de¢ciency as a cause of hyponatraemia. A number of studies have demonstrated increased concentrations of 17-OHP in the sick newborn subsequently shown to have normal adrenocortical function, but values tended to be below 65 nmol/ L in almost all these cases, including those of premature sick infants. 4^6 However, there are two recorded cases of plasma 17-OHP concentrations in pre-term sick babies reaching values of 95 and 110 nmol/ L. 4 A moderately elevated value (59 nmol/ L) in a male infant during an episode of sepsis and hyponatraemia led to the diagnosis of CAH and commencement of steroid therapy. 5 Many months later CAH was eventually excluded and steroid replacement discontinued when adrenocortical function was shown to be normal. Therefore, it is generally accepted that an elevated plasma 17-OHP concentration of up to 110 nmol/ L in a sick infant may not be synonymous with 21-hydroxylase de¢ciency. This is also consistent with our own experience in applying the same in-house, solvent extraction RIA over a period of 25 years in our laboratory, during which time we have not encountered a plasma 17-OHP concentration above 100 nmol/ L in any non-premature, non-CAH babies, in a wide variety of clinical conditions. Despite a signi¢cantly greater 17-OHP concentration found in the current case, diagnosis of 21-hydroxylase de¢ciency remained in doubt. The main reasons for this conclusion were the normality of the baby's genitalia (fortuitously being a female) and, importantly, the concomitant gross increase in plasma cortisol concentration, ¢ndings which were inconsistent with CAH. In the majority of cases of 21hydroxylase de¢ciency (partial or complete) in which plasma 17-OHP and cortisol concentrations have both been measured, the raised plasma 17-OHP concentration has generally been associated with low or`lown ormal' plasma cortisol. 7 An example of this from our own records is a 30-min Synacthen stimulation performed on a female neonate with partial 21-hydroxylase de¢ciency and of comparable age to the current case (12 weeks). Plasma 17-OHP concentration rose from 77 to more than 300 nmol/ L but the plasma cortisol only increased from 182 to 241 nmol/ L. In the acutely ill infant, it appears that simultaneous measurement of both plasma 17-OHP and cortisol could aid interpretation and prevent potential misdiagnosis leading to mismanagement, especially in male infants. Other biochemical parameters measured, such as adrenal androgens, parallelled changes in 17-OHP and were of limited value. It may be of interest to highlight the nature of the illness in the case described and its likely impact on adrenocortical function. Chest infection is a common cause of excessive and inappropriate secretion of arginine vasopressin/antidiuretic hormone (AVP/ADH), promoting water retention and hyponatraemia. The AVP also stimulates adrenocorticotrophic hormone secretion 8 and this, together with the stress of illness, may have caused hyperstimulation of the adrenal glands, resulting in gross elevation of all adrenocortical steroids. Treatment of the chest infection resulted in rapid decrease in steroid concentrations and a subsequent short Synacthen stimulation test excluded, with con¢dence, partial 21-hydroxylase de¢ciency and con¢rmed normal adrenocortical function.
Conclusion
We show that an increase in plasma 17-OHP to concentrations typically found in 21-hydroxylase de¢ciency occurred in a full-term, sick baby with normal but hyperstimulated adrenal function. Measurement of plasma cortisol concentration was a useful adjunct in establishing CAH as an unlikely diagnosis.
